A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia
This study has been completed.
Study NCT00249223
Information provided by Janssen Pharmaceutica N.V., Belgium
First Received on November 4, 2005.
Last Updated on January 13, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
